Navigation Links
Norfolk PCTs To Offer Herceptin

There's joy and relief at Norfolk as surgeons at the Norfolk and Norwich University Hospital have been given the green signal to make available the breast// cancer drug Herceptin to women who test positive for her-2 gene.

"We made the business case and submitted it to the therapeutic advisory groups, and the primary care trusts have backed the package," confirmed Simon Pain, consultant breast surgeon at the N&N. "About one in five women with breast cancer will be sensitive to Herceptin. We will test every breast cancer patient for it and if they are sensitive to it and it needs prescribing, then we will prescribe it." Some guidelines have been put into place for the women to be eligible to take the drug. Firstly a woman must test positive for the HER-2 receptor. But since only 20 percent carry this receptors, it is felt that this decision will only benefit a minority. "I think the results from Herceptin are probably the most significant and impressive from any single drug for breast cancer. And I think for those one in five women this is a great leap forward and those tested will be offered the drug if deemed appropriate," Pain said. "We have already been using Herceptin for some time for patients with advanced disease but the evidence shows it can be of use in early stages post-op." As of now, Herceptin is still not licensed for use in early stages of breast cancer and NICE (National Institute of Health and Clinical Excellence) is yet to clarify the matter.
'"/>




Page: 1

Related medicine news :

1. Culling Complete at Norfolk farms
2. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
3. Drug Offers Hope for Alzheimers disease
4. Drug Firm Offers to Donate Smallpox Vaccine
5. Stem Cells Found To Offer Promise For Hair Growth
6. fMRI Offers Insight Into An Infants Brain
7. Diet Found To Offer Protection Against Leukemia
8. Gel Offers A More Targeted Approach
9. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
10. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
11. A New Product Offering protection against anthrax
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: